RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

CENTAURUS FINANCIAL, INC.'s Holding History (CIK: 0000891943)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 17,165 Value ($000) $0 Avg Close $4.95 Range $3.81 - $7.18
Q3 2025
Shares 16,765 Value ($000) $0 Avg Close $5.25 Range $4.45 - $7.15
Q2 2025
Shares 14,665 Value ($000) $0 Avg Close $4.91 Range $3.79 - $6.11
Q1 2025
Shares 11,110 Value ($000) $0 Avg Close $7.29 Range $5.19 - $12.36
Q4 2024
Shares 10,774 Value ($000) $0 Avg Close $6.72 Range $5.60 - $9.55
Q3 2024
Shares 10,774 Value ($000) $0 Avg Close $7.17 Range $5.88 - $8.73
Q2 2023
Shares 13,242 Value ($000) $0 Avg Close $7.00 Range $4.54 - $10.45
Q1 2023
Shares 11,023 Value ($000) $0 Avg Close $7.93 Range $6.40 - $9.73
Q4 2022
Shares 11,023 Value ($000) $0 Avg Close $9.81 Range $7.04 - $13.29
Q3 2022
Shares 10,023 Value ($000) $107 Avg Close $10.13 Range $7.48 - $14.18
Q2 2022
Shares 10,023 Value ($000) $82 Avg Close $6.69 Range $4.92 - $9.40